T-Cypher Bio reports promising cancer cell killing with two next-generation T-cell engagers.
T-Cypher Bio reports promising TC25 and TC11 cancer immunotherapy data. Find out how its T-cell engagers could reshape solid tumor treatment.
Pharma & Biotech